Health is prominent on the agenda of media, politicians and the general public. We help turn focus onto specific issues and lift them into the arena of health policy.
We facilitate debate on current challenges
We design strategies for political communication within various disease areas in collaboration with our clients. We carry out stakeholder analyses, arrange round-table discussions and debates, and advise on dialogue with political decision-makers.
Public affairs include:
We collaborate across disciplines
We have a large network within various disease areas and collaborate across disciplines with relevant stakeholders to ensure that we deliver political communication that secures action.
Would you like help with public affairs?
Contact us or drop by our offices in Copenhagen.
Trine Petersen, Director of Analysis, Market Access and Public Affairs
+45 20 60 28 25
We ensure a place in the market for pharmaceutical products by highlighting their value.
We are dedicated to life science communication and to making a difference for our clients. We believe the two are inseparably linked.
We deliver communication that adds value – from strategy, through development and production, to implementation.
We are passionate about what we do. We understand the details and can communicate the nuances. We find great inspiration in working in the cross field between people, politics and science. It requires empathy, integrity and insight, and it is a precondition for producing results.
We believe in specialisation – at industry and employee level, and in relation to our business partners. We always appoint the best team for the task.
We understand and adhere to the ethical regulations in the Nordic markets as laid down by the European Federation of Pharmaceutical Industries and Associations (EFPIA), by Creativity and Communication, The Association of Advisory Creative Business and by the Confederation of Danish Enterprise. We consider this mandatory when working with a highly regulated field such as the pharmaceutical and life science industry. Read more.